Continuous Glucose Monitoring Market By Type (Transmitter & Receivers, Sensors, and Insulin Pump), By Application (Diagnostics/Clinics, Hospitals, and Home Settings), Industry Trends, Estimation & Forecast, 2023-2030

Market Overview

Continuous glucose monitoring (CGM) is a mode of tracking blood glucose levels, also called blood sugar. CGM measures the glucose in interstitial fluid through a sensor placed just under the skin. Continuous glucose monitoring consists of three components the sensor, transmitter, and receiver. The sensor is a thin filament or wire, inserted with the aid of a needle under the skin. The transmitter is the middleman between the sensor and the receiver. Transmitter are attached to the top of the area where the sensor was inserted. The receiver, receive and display the information from the sensor, and check the current glucose levels and view past readings in the display.

Global Continuous Glucose Monitoring market is estimated to reach $7,572.8 Million.

Market Dynamics

Rising incidence of diabetes is boosting the global Continuous Glucose Monitoring market. For instance, According to the European Society of Cardiology, the prevalence of diabetes is 8.8% of the world population in 2017. The prevalence is expected to increase by 9.9% in 2045. The global population with diabetes was 424.9 million in 2017, with an estimate of a 48% increase to 628.6 million people for the year 2045. According to Centers for Disease Control (CDC), in the U.S, diabetes had risen to an estimated 30.3 million in 2017. About 90% of people have Type 2 diabetes, and 8% of people with Type 1 diabetes, and 2% of people have rarer types of diabetes. According to Diabetes UK, more than five million people will have diabetes in the UK by 2025. Increasing regulatory approval for continuous glucose monitoring are key driving factors of the market. However, Undiagnosed population from diabetes might hamper the market growth. For instance, According to Centers for Disease Control (CDC), more than 70% of diabetic patients reside in developing and under-developed countries. According to Centers for Disease Control (CDC), 7.2 million, which is 23.8% of U.S population with diabetes are undiagnosed. Increasing pipeline devices of continuous glucose monitoring would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global Continuous Glucose Monitoring market is mainly classified based on Type, Application. Type is further segmented into Transmitter & Receivers, Sensors, Insulin Pump. Sensors are dominating the global continuous glucose monitoring market by type. Sensors are placed under the skin to measure glucose in the body fluid. The sensor should be replaced every 7-14 days, depending on the model. The regulatory approvals for continuous glucose monitoring sensors are boosting the market. For instance, The U.S. Food and Drug Administration (FDA) has approved Eversense continuous glucose monitoring (CGM) system with an implantable glucose sensor that can be worn for up to 90 days, as opposed to 7 days like many other sensors. The market is further segmented by Application; the market is divided into Diagnostics/Clinics, Hospitals, Home Settings.

Regional Analysis

Based on geography, the global Continuous Glucose Monitoring market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is dominating the global continuous glucose monitoring market due to increasing regulatory approval of continuous glucose monitoring. For instance, October 8, 2019, Dexcom, Inc. has received the U.S. Food and Drug Administration (FDA) approval for Dexcom G6 Pro Continuous Glucose Monitoring System for healthcare professionals to use for ages two years and up. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Market Leaders

Key players operating in the Continuous Glucose Monitoring industry include Medtronic plc, Abbott, DexCom, Insulet, Senseonics, Roche, GlySure, Animas, Tandem Diabetes Care, Inc.

The strategic agreement by companies for product expansion and generating revenue is boosting the market growth. For instance, December 16, 2019, Eli Lilly and Company has signed a global commercialization agreement to integrate DexCom, Inc. products into Lilly’s personalized diabetes management system. Under the non-exclusive agreement, Lilly will use Dexcom’s continuous glucose monitoring (CGM) devices in both the pen- and pump-based platforms of the system being designed to help improve diabetes management. The regulatory approval for continuous glucose monitoring (CGM) device is driving the market. September 17, 2019, Medtronic plc has received CE (ConformitéEuropéenne) Mark approval for Envision Pro Continuous Glucose Monitoring (CGM) system, a fully disposable, zero calibration professional CGM system. Envision Pro technology is used for type 1 and type 2 diabetes to measure glucose.

Continuous Glucose Monitoring Market Key Segments

By Type
• Transmitter & Receivers
• Sensors
• Insulin Pump

By Application
• Diagnostics/Clinics
• Hospitals
• Home Settings
 
By Geography

• North America
o The U.S.
o Canada
o Mexico
• Europe
o U.K
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific
o India
o China
o Japan
o South Korea
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Rest of South America
• Middle East & Africa
o GCC Countries
o Egypt
o South Africa
o Rest of Middle East & Africa
 
Key Global Continuous Glucose Monitoring Industry Players

• Medtronic plc
• Abbott
• DexCom
• Insulet
• Senseonics
• Roche
• GlySure
• Animas
• Tandem Diabetes Care, Inc.

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Continuous Glucose Monitoring Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Rising incidence of diabetes
3.3.2. Increasing regulatory approval for continuous glucose monitoring
3.4. Restraints
3.4.1. Undiagnosed population from diabetes
3.5. Opportunity
3.5.1. Increasing pipeline devices of continuous glucose monitoring
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Transmitter & Receivers
4.2.1. Market Size & Forecast
4.3. Sensors
4.3.1. Market Size & Forecast
4.4. Insulin Pump
4.4.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Diagnostics/Clinics
5.2.1. Market Size & Forecast
5.3. Hospitals
5.3.1. Market Size & Forecast
5.4. Home Settings
5.4.1. Market Size & Forecast

6. Continuous Glucose Monitoring Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Continuous Glucose Monitoring Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By Application
6.2.4. The U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Continuous Glucose Monitoring Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By Application
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Continuous Glucose Monitoring Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By Application
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Continuous Glucose Monitoring Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By Application
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Continuous Glucose Monitoring Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By Application
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast

7. Company Profile
7.1. Medtronic plc
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. Medtronic plc Product Category, Application, and Specification
7.1.3. Medtronic plc Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. Abbott
7.3. DexCom
7.4. Insulet
7.5. Senseonics
7.6. Roche
7.7. GlySure
7.8. Animas
7.9. Tandem Diabetes Care, Inc.